Dorte Lisbet Nielsen

Dorte Lisbet Nielsen

Professor emeritus.

Member of:

  • Clinical Oncology


  1. 2018
  2. Published

    Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study

    Buhl, A. S. K., Christensen, T. D., Christensen, I. J., Nelausen, K. M., Balslev, E., Knoop, A. S., Brix, E. H., Svensson, E., Glavicic, V., Luczak, A., Langkjer, S. T., Linnet, S., Jakobsen, E. H., Bogovic, J., Ejlertsen, B., Rasmussen, A., Hansen, A., Knudsen, S., Nielsen, Dorte Lisbet & Jensen, P. B., 2018, In: Breast Cancer Research and Treatment. 172, 2, p. 391-400 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Safety and feasibility of home-based chemotherapy

    Larsen, F. O., Christiansen, A. B., Rishøj, A., Nelausen, K. M. & Nielsen, Dorte Lisbet, 2018, In: Danish Medical Journal. 65, 5, 5 p., A5482.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer

    Kalanxhi, E., Meltzer, S., Schou, J. V., Larsen, F. O., Dueland, S., Flatmark, K., Jensen, B. V., Hole, K. H., Seierstad, T., Redalen, K. R., Nielsen, Dorte Lisbet & Ree, A. H., 2018, In: British Journal of Cancer. 118, 10, p. 1322-1328 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    The Patient–Healthcare Professional Relationship and Communication in the Oncology Outpatient Setting: A Systematic Review

    Prip, A., Møller, K. A., Nielsen, Dorte Lisbet, Jarden, Mary Ellen, Olsen, M. H. & Danielsen, A., 2018, In: Cancer Nursing. 41, 5, p. E11-E22 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  6. 2017
  7. Published

    Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer

    Larsen, F. O., Markussen, A., Nielsen, Dorte Lisbet, Colville-Ebeling, B., Riis, Lene Buhl & Jensen, B. V., Sep 2017, In: Oncology. 93, 3, p. 191-196 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review

    Nielsen, Dorte Lisbet, Palshof, J. A., Bruenner, N., Stenvang, Jan & Viuff, B. M., Sep 2017, In: International Journal of Molecular Sciences (Online). 18, 9, 16 p., 1926.

    Research output: Contribution to journalReviewResearchpeer-review

  9. Published

    The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO)

    Lund, C. M., Vistisen, K. K., Dehlendorff, C., Rønholt, F., Johansen, Julia Sidenius & Nielsen, Dorte Lisbet, 28 Jun 2017, In: B M C Cancer. 17, 9 p., 448.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer

    Palshof, J. A., Høgdall, Estrid Vilma Solyom, Poulsen, T. S., Linnemann, D., Jensen, B. V., Pfeiffer, P., Tarpgaard, L. S., Brunner, N., Stenvang, Jan, Yilmaz, M. & Nielsen, Dorte Lisbet, 11 Jan 2017, In: BMC Cancer. 17, 10 p., 48.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial

    Ejlertsen, B., Tuxen, M. K., Jakobsen, E. H., Jensen, M., Knoop, A. S., Højris, I., Ewertz, M., Balslev, E., Danø, H., Vestlev, P. M., Kenholm, J., Nielsen, Dorte Lisbet, Bechmann, T., Andersson, M., Cold, S., Nielsen, H. M., Maae, E., Carlsen, D. & Mouridsen, H. T., 2017, In: Journal of Clinical Oncology. 35, 23, p. 2639-2646

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Performance of seven criteria to assess CA125 increments among ovarian cancer patients monitored during first-line chemotherapy and the post-therapy follow-up period

    Abu Hassan, S. O., Nielsen, Dorte Lisbet, Tuxen, M. K., Petersen, P. H. & Sölétormos, G., 2017, In: Future Science O A. 3, 3, 12 p., FSO216.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 10804194